Bionik Laboratories Corp. (OTCMKTS:BNKL) Files An 8-K Other Events
Item 8.01
| Other Events |
On December 20, 2016, Bionik Laboratories Corp. (the Registrant)
issued a press release disclosing that the Registrant is
advancing the InMotion AnkleBot from research use into commercial
development.
A copy of the press release is filed as Exhibit 99.1 to this
Current Report on Form 8-K and is incorporated herein by
reference.
| Item 9.01 | Financial Statements and Exhibits |
| (d) | Exhibits |
| Exhibit No. | Description |
| 99.1 | Press Release of the Registrant, dated December 20, 2016 |
About Bionik Laboratories Corp. (OTCMKTS:BNKL)
Bionik Laboratories Corp. (Bionik), formerly Drywave Technologies, Inc., is a medical device and robotics company. The Company is focused on providing rehabilitation solutions and developing transformational technologies and solutions to individuals with neurological disorders, specializing in the designing, developing and commercializing of physical rehabilitation technologies, prosthetics and assisted robotic products. It has over three products on the market and approximately three products in various stages of development. The InMotion Systems include the InMotion ARM, InMotion HAND, InMotion Wrist and InMotion ANKLE are designed to provide patent-adaptive therapy in a manner that has been clinically verified to manage neuro-recovery. The Company is also engaged in developing a lower-body exoskeleton, ARKE, which designs to allow paraplegics, as well as other wheelchair users the ability to rehabilitate through walking. Bionik Laboratories Corp. (OTCMKTS:BNKL) Recent Trading Information
Bionik Laboratories Corp. (OTCMKTS:BNKL) closed its last trading session down -0.010 at 0.690 with 2,000 shares trading hands.
